[ 1] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 2] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 3] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 4] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 5] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 6] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 7] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 8] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 9] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 10] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 11] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 12] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 13] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 14] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 15] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 16] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 17] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 18] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 19] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 20] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 21] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 22] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 23] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 25] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 26] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 27] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 28] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 29] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 30] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 31] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 32] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 33] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 34] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 35] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 36] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 37] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 38] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 39] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 40] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 41] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 42] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 43] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 44] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 45] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 47] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 48] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 49] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 50] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 51] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 52] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 53] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 55] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 56] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 57] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 58] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 59] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 60] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 61] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 62] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 63] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 64] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 65] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 66] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 67] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 68] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 69] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 70] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 71] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 72] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 73] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 74] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 75] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 76] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 77] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 78] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 79] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 80] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 81] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 82] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 83] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 84] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 85] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 86] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 87] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 88] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 89] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 90] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 91] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 92] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 93] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 94] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 95] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 96] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 97] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 98] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 99] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [100] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [101] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [102] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [103] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [104] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [108] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [109] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [110] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [111] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [112] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [113] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [114] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [115] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [116] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [117] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [118] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [119] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [120] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [123] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [124] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [126] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [127] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [128] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [129] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [130] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [131] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [132] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [133] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [134] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [137] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [140] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [141] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [142] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [143] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [144] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [145] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [148] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [149] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [150] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [151] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [152] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [154] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [155] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [156] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [157] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [158] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [159] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [160] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [164] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [165] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [166] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [167] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [168] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [169] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [170] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [171] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [172] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [173] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [176] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [177] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [178] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [179] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [181] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [182] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [183] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [184] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [185] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [186] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [187] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [188] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [189] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [190] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [193] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [195] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [198] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [199] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [200] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [201] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [202] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [203] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [204] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [205] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [206] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [208] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [209] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [210] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [211] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [212] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [213] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [214] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [215] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [216] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [217] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [218] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [219] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [220] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [221] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [222] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [223] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [224] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [225] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [226] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [228] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [229] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [230] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [231] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [232] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [233] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [236] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [237] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [238] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [239] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [242] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [243] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [244] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [245] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [246] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [247] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [248] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [249] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [252] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [253] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [254] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [255] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [260] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [261] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [262] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [263] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [264] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [265] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [266] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [267] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [268] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [270] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [271] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [272] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [273] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [274] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [275] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [276] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [277] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [278] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [279] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [280] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [281] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [282] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [283] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [286] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [287] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025".